Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYRN

Cyren (CYRN) Stock Price, News & Analysis

Cyren logo

About Cyren Stock (NASDAQ:CYRN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.21
$0.92
52-Week Range
N/A
Volume
1.15 million shs
Average Volume
1.43 million shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter.

CYRN Stock News Headlines

Peyto Exploration&Development Corp (PEY)
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Why Is Cyren (CYRN) Stock Down 27% Today?
Cyren Announces Nasdaq Delisting Determination
Cyren Announces Liquidation
Why Is Cyren (CYRN) Stock Up 43% Today?
See More Headlines

CYRN Stock Analysis - Frequently Asked Questions

Cyren Ltd. (NASDAQ:CYRN) announced its quarterly earnings results on Monday, November, 15th. The technology company reported ($0.06) earnings per share for the quarter, hitting the consensus estimate of ($0.06). The technology company earned $7.46 million during the quarter. Cyren had a negative net margin of 123.96% and a negative trailing twelve-month return on equity of 206.16%.

The following companies are subsidiaries of Cyren: eleven GmbH, FRISK Software International, Authentium, Wingtra, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., and Cyren UK Ltd..

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyren investors own include Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT), Acasti Pharma (ACST), iBio (IBIO), Oragenics (OGEN) and OpGen (OPGN).

Company Calendar

Last Earnings
11/15/2021
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRN
CIK
1084577
Employees
200
Year Founded
1991

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.04 million
Net Margins
-123.96%
Pretax Margin
-94.37%

Debt

Sales & Book Value

Annual Sales
$31.19 million
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
N/A

Miscellaneous

Free Float
7,539,000
Market Cap
$1.70 million
Optionable
Not Optionable
Beta
0.83

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:CYRN) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners